GBA1 and Parkinson disease: The inclusion of genetic subgroups (LRRK2 and GBA1 mutations) facilitates stratified analyses, revealing mutation-specific metabolic patterns, such as reduced caffeine and paraxanthine levels in LRRK2 carriers, which align with recent findings on gene-environment interactions in PD.